European Journal of Cardio-Thoracic Surgery Advance Access published July 4, 2015
ORIGINAL ARTICLE
European Journal of Cardio-Thoracic Surgery (2015) 1–6 doi:10.1093/ejcts/ezv233
Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b–5 chronic kidney disease Anna Lautamäkia, Tuomas Kiviniemia, Fausto Biancarib, Juhani Airaksinena, Tatu Juvonenb and Jarmo Gunna,* a b
Heart Center, Turku University Hospital and University of Turku, Turku, Finland Department of Surgery, Oulu University Hospital, Oulu, Finland
* Corresponding author. Heart Center, Turku University Hospital, PO Box 52, 20521 Turku, Finland. Tel: +35-823-130000; e-mail: jarmo.gunn@tyks.fi, jamigu@utu.fi ( J. Gunn). Received 2 February 2015; received in revised form 13 May 2015; accepted 3 June 2015
Abstract OBJECTIVES: Patients with chronic kidney disease (CKD) are generally considered to be at an increased risk for cardiovascular events and cardiac mortality. The prognostic significance of severe renal impairment in patients undergoing coronary revascularization remains mainly unknown because these patients have been excluded from randomized clinical trials. The aim of the present study was to compare the outcome after percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with an estimated glomerular filtration rate (eGFR) of
ORIGINAL ARTICLE
European Journal of Cardio-Thoracic Surgery (2015) 1–6 doi:10.1093/ejcts/ezv233
Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b–5 chronic kidney disease Anna Lautamäkia, Tuomas Kiviniemia, Fausto Biancarib, Juhani Airaksinena, Tatu Juvonenb and Jarmo Gunna,* a b
Heart Center, Turku University Hospital and University of Turku, Turku, Finland Department of Surgery, Oulu University Hospital, Oulu, Finland
* Corresponding author. Heart Center, Turku University Hospital, PO Box 52, 20521 Turku, Finland. Tel: +35-823-130000; e-mail: jarmo.gunn@tyks.fi, jamigu@utu.fi ( J. Gunn). Received 2 February 2015; received in revised form 13 May 2015; accepted 3 June 2015
Abstract OBJECTIVES: Patients with chronic kidney disease (CKD) are generally considered to be at an increased risk for cardiovascular events and cardiac mortality. The prognostic significance of severe renal impairment in patients undergoing coronary revascularization remains mainly unknown because these patients have been excluded from randomized clinical trials. The aim of the present study was to compare the outcome after percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with an estimated glomerular filtration rate (eGFR) of
